Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazole

• Published in: Experimental parasitology 2016-11, Vol.170, p.1-9
• Main Authors: dos Santos, Paula F., Moreira, Douglas S., Baba, Elio H., Volpe, Caroline M.O., Ruiz, Jerônimo C., Romanha, Alvaro J., Murta, Silvane M.F.
• Format: Article
• Language: English
• Subjects: Alleles; Amino Acid Sequence; Animals; Benznidazole; Blotting, Northern; Blotting, Southern; Cloning, Molecular; Dihydrolipoamide Dehydrogenase - chemistry; Dihydrolipoamide Dehydrogenase - genetics; DNA, Protozoan - chemistry; DNA, Protozoan - isolation & purification; Drug resistance; Drug Resistance - genetics; Gene Dosage; Gene Expression Regulation, Enzymologic; Lipoamide dehydrogenase; Mice; Mitochondria - enzymology; Nitroimidazoles - pharmacology; Phylogeny; Real-Time Polymerase Chain Reaction; Recombinant Proteins - chemistry; Recombinant Proteins - genetics; Recombinant Proteins - isolation & purification; RNA, Messenger - metabolism; RNA, Protozoan - chemistry; RNA, Protozoan - isolation & purification; Sequence Analysis, DNA; Trypanocidal Agents - pharmacology; Trypanosoma cruzi; Trypanosoma cruzi - drug effects; Trypanosoma cruzi - enzymology; Trypanosoma cruzi - genetics
• ISSN: 0014-4894; 1090-2449
• DOI: 10.1016/j.exppara.2016.08.006

Lipoamide dehydrogenase (LipDH) is a flavin-containing disulfide oxidoreductase from the same group of thioredoxin reductase, glutathione reductase and trypanothione reductase. This enzyme is found in the mitochondria of all aerobic organisms where it takes part in at least three important multienzyme complexes from the citric acid cycle. In this study, we performed a phylogenetic analysis comparing the amino acid sequence of the LipDH from Trypanosoma cruzi (TcLipDH) with the LipDH from other organisms. Subsequently, the copy number of the TcLipDH gene, the mRNA and protein levels, and the enzymatic activity of the LipDH were determined in populations and strains of T. cruzi that were either resistant or susceptible to benznidazole (BZ). In silico analysis showed the presence of two TcLipDH alleles in the T. cruzi genome. It also showed that TcLipDH protein has less than 55% of identity in comparison to the human LipDH, but the active site is conserved in both of them. Southern blot results suggest that the TcLipDH is a single copy gene in the genome of the T. cruzi samples analyzed. Northern blot assays showed one transcript of 2.4 kb in all T. cruzi populations. Northern blot and Real Time RT-PCR data revealed that the TcLipDH mRNA levels were 2-fold more expressed in the BZ-resistant T. cruzi population (17LER) than in its susceptible pair (17WTS). Western blot results revealed that the TcLipDH protein level is 2-fold higher in 17LER sample in comparison to 17WTS sample. In addition, LipDH activity was higher in the 17LER population than in the 17WTS. Sequencing analysis revealed that the amino acid sequences of the TcLipDH from 17WTS and 17LER populations are identical. Our findings show that one of the mechanisms associated with in vitro-induced BZ resistance to T. cruzi correlates with upregulation of LipDH enzyme. [Display omitted] •Lipoamide dehydrogenase (LipDH) gene was characterized in 8 strains and clones of T. cruzi.•In silico analysis showed the presence of two TcLipDH alleles.•TcLipDH mRNA levels were 2-fold higher in BZ-resistant T. cruzi population.•TcLipDH protein expression level was 2-fold higher in BZ-resistant T. cruzi population.•LipDH activity was higher in BZ-resistant T. cruzi population.